Catalyst Wire Dossier Catalyst Wire Dossier

Flurbiprofen 8.75 mg lozenge

flurbiprofen · Reckitt Benckiser LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Flurbiprofen 8.75 mg lozenge, covering 2017-09-21 to 2017-09-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis [Phase 3]

See pricing